Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium
Lijuan Deng(Shandong University of Traditional Chinese Medicine), Ken H. Young(Duke Medical Center), Jeremy S. Abramson(Massachusetts General Hospital), Karen Dybkær(Aalborg University Hospital), S Wang(National University Hospital), Benjamin M. Parsons(Gundersen Health System), Maurilio Ponzoni(San Raffaele University of Rome), Ling Li(Zhengzhou University), Anamarija M. Perry(University of Michigan), Eric D. Hsi(Mayo Clinic), Jun Zhu(Peking University), Y Li(Roche (Switzerland)), Zijun Y. Xu‐Monette(Duke University), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Qiong-Li Zhai(Tianjin Medical University Cancer Institute and Hospital), L Zhang(The University of Texas MD Anderson Cancer Center), Sanam Loghavi(The University of Texas MD Anderson Cancer Center), April Chiu(Mayo Clinic), Shuai Zhang(Second Military Medical University), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Mina L. Xu(Yale Cancer Center), Ganiraju C. Manyam(The University of Texas MD Anderson Cancer Center), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Aliyah R. Sohani(Massachusetts General Hospital), Jooryung Huh(Asan Medical Center), Yan Wang(Jiangsu Provincial Center for Disease Control and Prevention), Yi Xia(The University of Texas MD Anderson Cancer Center), Hui Rao(Sun Yat-sen University), L. Jeffrey Medeiros(Delaware Division of Libraries), M. Zhang(Zhengzhou University), Lihua Qiu(Tianjin Medical University Cancer Institute and Hospital)
Cited by 83
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
|Cell|2016|2.4k